|
| FGF-2与肌肉减少症的研究进展 |
| Research progress on FGF-2 and sarcopenia |
| |
| DOI:10.3969/j.issn.1006-7108.2026.11.022 |
| 中文关键词: FGF-2 肌少症 肌少-骨质疏松症 |
| 英文关键词:FGF-2 sarcopenia osteosarcopenia |
| 基金项目:山西省大健康产业高质量发展科研专项课题(DJKZXKT2023044) |
|
| 摘要点击次数: 51 |
| 全文下载次数: 0 |
| 中文摘要: |
| 肌肉减少症(肌少症)是随年龄进展的骨骼肌退行性综合征。FGF-2作为关键肌因子,在肌少症中的作用极其复杂。一方面,FGF-2通过激活RAS/MAPK、PI3K/AKT、PLCγ等经典通路促进肌修复与再生;另一方面,FGF-2在衰老微环境中却可通过miR-29a/SPARC轴与CSPG4机制反常地促进肌内脂肪(IMAT)沉积。这种“双重作用”是目前FGF-2研究的核心矛盾。此外,FGF-2作为“肌-骨串扰”的信使,可通过抑制硬骨素(sclerostin)和肌生成抑制素(myostatin)发挥“肌-骨同治”的潜力,为“肌少-骨质疏松症”的干预提供了新思路。本文重点综述FGF-2在肌少症中的“双重作用”与“肌-骨串扰”机制,并探讨其作为生物标志物(如FGF2甲基化)和选择性调控靶点的临床转化挑战。 |
| 英文摘要: |
| Sarcopenia is an age-progressive degenerative skeletal muscle syndrome. As a key myokine, the role of FGF-2 in sarcopenia is extremely complex. On one hand, FGF-2 promotes muscle repair and regeneration by activating classic pathways such as RAS/MAPK, PI3K/AKT, and PLCγ. On the other hand, in the aging microenvironment, FGF-2 can paradoxically promote intramuscular adipose tissue (IMAT) accumulation via the miR-29a/SPARC axis and CSPG4-dependent mechanisms. This "dual role" represents a core paradox in current FGF-2 research. Furthermore, as a messenger in "muscle-bone crosstalk," FGF-2 exhibits the potential for "dual muscle-bone therapy" by inhibiting sclerostin in bone and myostatin in muscle, offering new insights for osteosarcopenia interventions. This review focuses on the "dual role" and "muscle-bone crosstalk" mechanisms of FGF-2 in sarcopenia, and discusses the clinical translational challenges of using it as a biomarker (e.g., FGF2 methylation) and as a selective regulatory target. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |